ecause exogenous adenosine is known to induce hyperemia, it is used clinically for Tl imaging 1 and coronary flow or pressure measurement. 2, 3 In Japan, ATP is used for this purpose instead of adenosine 4 because when administered intravenously, ATP is degraded to adenosine; therefore, the effects of adenosine and ATP are considered essentially the same. However, the direct effect of exogenous ATP might be manifiested through adenine nucleotide receptors (P2X, P2Y) in addition to its effect as adenosine through the adenosine receptors (A1, A2, A3).
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Adenosine A2 receptor stimulation relaxes smooth muscle via the stimulation of adenylyl cyclase activity. KATP channel opening via the A1 receptor stimulation may also relax vascular muscle. In cardiac muscle, A1 receptor stimulation has a negative inotropic effect: 5 it decreases adenylyl cyclase activity, decreases L-type Ca current (ICa), shortens the action potential duration 6 and inhibits contraction. 5 During continuous ATP injection, the direct effect of ATP should be considered in addition to the effect of its metabolite, adenosine. ATP induces vasodilation through the P2Y receptor, which is endothelium-dependent, and vasoconstriction through the P2X receptor. P2Y receptor stimulation inhibits cardiac muscle contraction through the inhibition of ICa. 7 Thus, there are many effects on cardiac and vascular smooth muscle from continuous ATP injection. Although the effect of adenosine on human hemodynamics is available from the literature, 2,8 the effect of continuous ATP injection is unknown and needs to be clarified.
Methods
This study was performed in patients undergoing cardiac catheterization for re-evaluation after percutaneous coronary intervention (PCI) or coronary aorta bypass graft surgery (CABG) in Saitama Cardiovascular and Respiratory Center. Patients with acute coronary syndrome, severe heart valve disease, systemic hypotension, bronchial asthma, and any degree of atrioventricular (AV) block were excluded. Patients whose electrocardiogram (ECG) was not showing normal sinus rhythm or whose left ventricular (LV) ejection fraction was less than 40% were also excluded. Informed consent was obtained from each patient before the study.
First, diagnostic coronary angiography was performed using the Jadkins' technique. If significant stenosis existed in a major coronary artery that was not protected by a bypass graft, the patient was withdrawn from the study. The total number of patients was 14 (13 male; 1 female; post PCI, 7; post CABG, 7; mean age, 65.2±2.5 years).
Right atrial pressure (RAP), right ventricular pressure (RVP) and pulmonary capillary wedge pressure (PCWP) were measured and the cardiac index (CI) and stroke volume index (SVI) were calculated using a thermodilution technique. The catheter was then mounted in the pulmonary artery (PA) and aorta (Ao) for simultaneous monitoring of stroke volume index (SVI), RVP and PAP were also measured. Data are expressed as mean ± SE for n patients. Student's t-test for paired samples was performed and statistical significance was verified at p<0.05 (two-tailed).
Results
During the ATP injection, minor complications appeared ( Table 1) : 13 of 14 patients had chest symptoms, which were transient in most cases or disappeared when the injection was stopped. One patient showed second-degree AV block (Mobitz II), which disappeared immediately after the end of the injection. Fig 1 shows the original traces of ECG, AoP and PAP before and during ATP injection. ATP significantly increased heart rate (HR) but decreased systolic AoP; overall, double product (DP) was maintained. ATP significantly decreased mean AoP. On the other hand, ATP did not decrease but rather increased RAP, PAP and PCWP. ATP increased CI and SVI. Systemic vascular resistance (SVR), total pulmonary resistance (TPR), and pulmonary arteriolar resistance (PAR) were all decreased by ATP ( Table 2) .
Discussion

Side Effect of ATP Injection
ATP was injected at the dose routinely used for Tl imaging. Almost all patients (13/14, 93%) had chest symptoms. Mehta et al reported that adenosine-induced chest pain is not related to myocardial ischemia, 9 but it is difficult to distinguish these symptoms from ischemia-induced symptoms outside the catheterization laboratory. In the present study, chest symptoms were not related to coronary artery stenosis, which was confirmed by coronary angiography.
Only 1 of the 14 patients showed second-degree AV block during ATP injection, but it disappeared immediately after the end of the injection. This effect is probably from adenosine-induced inhibition of the AV node. Adenosine opens muscarinic K + channels, which are concentrated in sinoatrial (SA) node and AV nodes, and so AV conduction might be inhibited. However, it is not sure why this inhibitory effect was not consistently observed in all patients. The dose used in the present study might not be enough to induce bradycardia in most of the patients.
Degradation of ATP and adenosine is very fast, so the serum concentration decreases very quickly and thus complications disappear immediately after the end of the injection. ATP can be used very safely. 
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Effect of ATP Injection onHR ATP and adenosine are considered to slow HR through the inhibition of both the SA and AV nodes. However, in the present study, ATP significantly increased HR, which is probably reflects the compensatory mechanism for its vasodilating effect. DP was maintained before and during the ATP injection. This increase in HR in response to a decrease in AoP is also observed when nifedipine 10 or hydralazine 11 is used (Table 3) .
ATP or adenosine-induced stimulation of sympathetic nerves 12 might also play a role in the increase in HR during ATP injection.
Effect of ATP Injection on Vascular Muscle
Intravenous injection of ATP induced a decrease in AoP and slight increase in PAP, RAP and PCWP. In the present study, ATP was injected from a peripheral vein, and its degradation occurred very quickly. It therefore appears possible that the concentrations of ATP and adenosine were different in the PA and Ao. The present results are qualitatively similar to those for adenosine, 2,8 so the effect of ATP on PAP is likely to occur through adenosine. As for the PA, an increase in CO overcomes a decrease in vascular resistance, which results in an increase in PAP, while vascular resistance decreases enough to decrease pressure in the Ao. However, the mechanism of the different effect of ATP or adenosine on the PA and Ao is still unknown. Adenosine receptor density may be different in these vessels.
Fullerton et al reported that a low concentration of adenosine decreases PAP without changing AoP in patients with pulmonary hypertension. 13 In the present study, the basal PAP was within normal limits, so the effect of ATP or adenosine might differ between patients with pulmonary hypertension and those without it.
In contrast to captopril 14 or nitroglycerin, 11 continuous ATP injection increased preload, observed as increases in RAP and PCWP. This increase in preload is also observed when adenosine is injected. According to Nussbacher et al, an increase in PCWP results from re-distribution of blood volume from the periphery to the central cortex. 8 
Effect of ATP Injection on Cardiac Function
It is very difficult to evaluate contractility in humans because contractility should be independent of preload and afterload. But in the clinic, CI, SVI or the ejection fraction (EF) are used as a parameters for cardiac function, all of which are dependent on both preload and afterload.
In the present study, ATP did not decrease CI but rather increased it, partly because of an increase in HR. In isolated cardiac muscle, ATP or adenosine shows a negative inotropic effect; however, ATP significantly increased CI, which could be attributed to an increase in preload, a decrease in afterload, and an increase in HR. (Table 3) Hydralazine and nifedipine increase HR in response to a decrease in AoP, as observed during ATP injection. Captropril and nitroglycerin decrease both preload and afterload, whereas hydralazine, nifedipine and diltiazem predominantly reduce afterload. A decrease in preload leads to a decrease in SVI, and a decrease in afterload leads to an increase in SVI; captopril and nitroglycerin do not alter SVI. Hydralazine, nifedipine, and diltiazem reduce afterload without affecting the preload, which favors to increase SVI. Hydralazine and diltiazem increase SVI but nifedipine fails to increase SVI, probably owing to a direct inhibitory effect on contractility. The effect of ATP is thus relatively similar to that of hydralazine.
Comparison With Other Vasodilators
Present results show that the effects of ATP and adenosine are essentially the same. The P2X and P2Y receptormediated effect might be small compared with the A1/A2 receptor-mediated effect. It also appears possible that the P2X and P2Y receptor-mediated effects are cancelled out by each other and masked by the A1/A2 receptor-mediated effect. 
